Numerical Distributions of Parasite Densities During Asymptomatic Malaria
Overview
Authors
Affiliations
Background: Asymptomatic parasitemia is common even in areas of low seasonal malaria transmission, but the true proportion of the population infected has not been estimated previously because of the limited sensitivity of available detection methods.
Methods: Cross-sectional malaria surveys were conducted in areas of low seasonal transmission along the border between eastern Myanmar and northwestern Thailand and in western Cambodia. DNA was quantitated by an ultrasensitive polymerase chain reaction (uPCR) assay (limit of accurate detection, 22 parasites/mL) to characterize parasite density distributions for Plasmodium falciparum and Plasmodium vivax, and the proportions of undetected infections were imputed.
Results: The prevalence of asymptomatic malaria as determined by uPCR was 27.5% (1303 of 4740 people tested). Both P. vivax and P. falciparum density distributions were unimodal and log normal, with modal values well within the quantifiable range. The estimated proportions of all parasitemic individuals identified by uPCR were >70% among individuals infected with P. falciparum and >85% among those infected with P. vivax. Overall, 83% of infections were predicted to be P. vivax infections, 13% were predicted to be P. falciparum infections, and 4% were predicted to be mixed infections. Geometric mean parasite densities were similar; 5601 P. vivax parasites/mL and 5158 P. falciparum parasites/mL.
Conclusions: This uPCR method identified most infected individuals in malaria-endemic areas. Malaria parasitemia persists in humans at levels that optimize the probability of generating transmissible gametocyte densities without causing illness.
Gilder M, Saito M, Haohankhunnatham W, Ling C, Gornsawun G, Bancone G PLoS Med. 2025; 22(3):e1004529.
PMID: 40036207 PMC: 11878921. DOI: 10.1371/journal.pmed.1004529.
Modeling the within-host dynamics of hypnozoite activation: An analysis of the SPf66 vaccine trial.
Mehra S, Nosten F, Luxemburger C, White N, Watson J Proc Natl Acad Sci U S A. 2024; 121(51):e2401024121.
PMID: 39656209 PMC: 11665876. DOI: 10.1073/pnas.2401024121.
Artemisinin-resistant malaria.
White N, Chotivanich K Clin Microbiol Rev. 2024; 37(4):e0010924.
PMID: 39404268 PMC: 11629630. DOI: 10.1128/cmr.00109-24.
Antwi-Baffour S, Mensah B, Ahiakonu S, Armah D, Ali-Mustapha S, Annison L BMC Immunol. 2024; 25(1):44.
PMID: 38987710 PMC: 11234552. DOI: 10.1186/s12865-024-00638-8.
Cespedes N, Fellows A, Donnelly E, Kaylor H, Coles T, Wild R Immunohorizons. 2024; 8(5):371-383.
PMID: 38780542 PMC: 11150129. DOI: 10.4049/immunohorizons.2300084.